| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway
|
Liang, Shun-Qing
|
|
|
30 |
1 |
p. 238-243
|
artikel
|
| 2 |
AAV-mediated gene editing lights up the lung
|
Yan, Ziying
|
|
|
30 |
1 |
p. 7-9
|
artikel
|
| 3 |
ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity
|
Wu, Xiaoting
|
|
|
30 |
1 |
p. 400-414
|
artikel
|
| 4 |
Advanced therapeutic strategy for hereditary neuromuscular diseases
|
Hwu, Wuh-Liang
|
|
|
30 |
1 |
p. 12-13
|
artikel
|
| 5 |
Anti-Cas9 immunity: A formidable challenge for muscle genome editing
|
Lagor, William R.
|
|
|
30 |
1 |
p. 10-12
|
artikel
|
| 6 |
Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats
|
Truong, Vu Anh
|
|
|
30 |
1 |
p. 92-104
|
artikel
|
| 7 |
Cardiac reprogramming via chromatin remodeling by CRISPR activation
|
Jahng, James W.S.
|
|
|
30 |
1 |
p. 6-7
|
artikel
|
| 8 |
Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition
|
Zhou, Jin
|
|
|
30 |
1 |
p. 244-255
|
artikel
|
| 9 |
circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway
|
Li, Yaming
|
|
|
30 |
1 |
p. 415-430
|
artikel
|
| 10 |
circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma
|
Li, Peng
|
|
|
30 |
1 |
p. 431-447
|
artikel
|
| 11 |
Cleavage-free human genome editing
|
Kuang, Chenzhong
|
|
|
30 |
1 |
p. 268-282
|
artikel
|
| 12 |
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease
|
Ramadier, Sophie
|
|
|
30 |
1 |
p. 145-163
|
artikel
|
| 13 |
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
|
Dastidar, Sumitava
|
|
|
30 |
1 |
p. 75-91
|
artikel
|
| 14 |
Controlling CRISPR with small molecule regulation for somatic cell genome editing
|
Khajanchi, Namita
|
|
|
30 |
1 |
p. 17-31
|
artikel
|
| 15 |
Correction of the pathogenic mutation in TGM1 gene by adenine base editing in mutant embryos
|
Dang, Lu
|
|
|
30 |
1 |
p. 175-183
|
artikel
|
| 16 |
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
|
Conforti, Antonella
|
|
|
30 |
1 |
p. 311-326
|
artikel
|
| 17 |
CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy
|
Jiang, Lin
|
|
|
30 |
1 |
p. 54-74
|
artikel
|
| 18 |
Dibenzazepine-Loaded Nanoparticles Induce Local Browning of White Adipose Tissue to Counteract Obesity
|
Jiang, Chunhui
|
|
|
30 |
1 |
p. 502
|
artikel
|
| 19 |
Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing
|
Knipping, Friederike
|
|
|
30 |
1 |
p. 130-144
|
artikel
|
| 20 |
Dual-AAV delivering split prime editor system for in vivo genome editing
|
Zhi, Shengyao
|
|
|
30 |
1 |
p. 283-294
|
artikel
|
| 21 |
Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control
|
Yu, Guiling
|
|
|
30 |
1 |
p. 341-354
|
artikel
|
| 22 |
Fecal miR-142a-3p from dextran sulfate sodium-challenge recovered mice prevents colitis by promoting the growth of Lactobacillus reuteri
|
He, Liuqin
|
|
|
30 |
1 |
p. 388-399
|
artikel
|
| 23 |
Gene editing in a Myo6 semi-dominant mouse model rescues auditory function
|
Xue, Yuanyuan
|
|
|
30 |
1 |
p. 105-118
|
artikel
|
| 24 |
Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment
|
Han, Xuan
|
|
|
30 |
1 |
p. 327-340
|
artikel
|
| 25 |
IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections
|
Kheir, Saadé
|
|
|
30 |
1 |
p. 355-369
|
artikel
|
| 26 |
In this issue
|
|
|
|
30 |
1 |
p. 4-5
|
artikel
|
| 27 |
In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment
|
Hong, Sung-Ah
|
|
|
30 |
1 |
p. 119-129
|
artikel
|
| 28 |
lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5
|
Jiang, Yingying
|
|
|
30 |
1 |
p. 448-467
|
artikel
|
| 29 |
Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension
|
Xing, Yan
|
|
|
30 |
1 |
p. 501
|
artikel
|
| 30 |
New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape
|
van Hees, Maja
|
|
|
30 |
1 |
p. 32-46
|
artikel
|
| 31 |
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer
|
Schirmer, Amelia U.
|
|
|
30 |
1 |
p. 485-500
|
artikel
|
| 32 |
Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges
|
Miccio, Annarita
|
|
|
30 |
1 |
p. 47-53
|
artikel
|
| 33 |
Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab
|
Banerjee, Rajat
|
|
|
30 |
1 |
p. 468-484
|
artikel
|
| 34 |
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques
|
AlJanahi, Aisha A.
|
|
|
30 |
1 |
p. 209-222
|
artikel
|
| 35 |
Preliminary outcomes reported from three randomized controlled trials of CD19 CAR-T cell therapies in large B cell lymphoma
|
Jain, Michael D.
|
|
|
30 |
1 |
p. 14-16
|
artikel
|
| 36 |
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections
|
Stief, Tanja A.
|
|
|
30 |
1 |
p. 198-208
|
artikel
|
| 37 |
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire
|
Ou, Tianling
|
|
|
30 |
1 |
p. 184-197
|
artikel
|
| 38 |
Retraction Notice to: miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells
|
Xiao, Jing
|
|
|
30 |
1 |
p. 503
|
artikel
|
| 39 |
RNA epitranscriptomics: A promising new avenue for cancer therapy
|
Yang, Chunlong
|
|
|
30 |
1 |
p. 2-3
|
artikel
|
| 40 |
Second installment of Special Issue on expanding the scale and scope of gene editing
|
Frederickson, Robert M.
|
|
|
30 |
1 |
p. 1
|
artikel
|
| 41 |
Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis
|
Wen, Jinkun
|
|
|
30 |
1 |
p. 164-174
|
artikel
|
| 42 |
Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus
|
Vaidyanathan, Sriram
|
|
|
30 |
1 |
p. 223-237
|
artikel
|
| 43 |
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasms
|
Snider, Douglas B.
|
|
|
30 |
1 |
p. 295-310
|
artikel
|
| 44 |
ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease
|
Vasconcelos-Ferreira, Ana
|
|
|
30 |
1 |
p. 370-387
|
artikel
|
| 45 |
Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9
|
Liu, Zhiquan
|
|
|
30 |
1 |
p. 256-267
|
artikel
|
Tijdschrift beschrijving